Chapter 9. Adrenal Cortical Carcinoma

  1. David Machin3,4,5,
  2. Simon Day6 and
  3. Sylvan Green7
  1. Isha Malik1 and
  2. Petros Perros2

Published Online: 17 MAY 2007

DOI: 10.1002/9780470010167.ch9

Textbook of Clinical Trials, Second Edition

Textbook of Clinical Trials, Second Edition

How to Cite

Malik, I. and Perros, P. (2006) Adrenal Cortical Carcinoma, in Textbook of Clinical Trials, Second Edition (eds D. Machin, S. Day and S. Green), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470010167.ch9

Editor Information

  1. 3

    Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, 11 Hospital Drive, Singapore 16910, Singapore

  2. 4

    UK Children's Cancer Study Group, University of Leicester, UK

  3. 5

    Medical Statistics Group, School of Health and Related Sciences, University of Sheffield, UK

  4. 6

    Licensing Division, Medicines and Healthcare products Regulatory Agency, Room 13–205 Market Towers, 1 Nine Elms Lane, London SW8 5NQ, UK

  5. 7

    Arizona Cancer Centre, Tucson, Arizona, USA

Author Information

  1. 1

    Specialist Registrar in Endocrinology, 154 Hampstead Road, Newcastle upon Tyne NE4 8AB, UK

  2. 2

    Endocrine Unit, Freeman Hospital, Freeman Road, Newcastle upon Tyne NE7 7DN, UK

Publication History

  1. Published Online: 17 MAY 2007
  2. Published Print: 24 NOV 2006

ISBN Information

Print ISBN: 9780470010143

Online ISBN: 9780470010167



  • Adrenal cortical carcinomas (ACC);
  • radiotherapy and unresectable tumours;
  • chemotherapy;
  • mitotane-based combination chemotherapy;
  • combination chemotherapy with cytotoxic agents


This chapter contains sections titled:

  • Introduction

  • Treatment

  • Conclusion

  • References